Global Retirement Partners, LLC Fate Therapeutics Inc Transaction History

Global Retirement Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$4.76 - $6.59 $1,413 - $1,957	-297 Reduced 72.79%	111 $0
Q1 2023 May 05, 2023	BUY	$4.24 - $11.12 $1,598 - $4,192	377 Added 1216.13%	408 $2,000
Q4 2022 Feb 13, 2023	BUY	$9.86 - $23.83 $305 - $738	31 New	31 $0
Q4 2020 Jan 13, 2021	SELL	$38.09 - $100.95 $1,333 - $3,533	-35 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$17.28 - $31.88 $604 - $1,115	35 New	35 $1,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $307M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.